KP Tissue Releases First Quarter 2025 Financial Results

In This Article:

KP Tissue Inc.
KP Tissue Inc.

Strong performance despite volatile economic environment

MISSISSAUGA, Ontario, May 14, 2025 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX: KPT) reports the Q1 2025 financial and operational results of KPT and Kruger Products Inc. (Kruger Products). Kruger Products is Canada's leading manufacturer of quality tissue products for the Consumer market (Cashmere®, Purex®, SpongeTowels®, Scotties®, White Swan® and BonterraTM) and the Away-From-Home (AFH) market and continues to grow in the U.S. Consumer tissue business with the White Cloud® brand and premium private label products. KPT currently holds a 12.3% interest in Kruger Products.

Kruger Products Q1 2025 Business and Financial Highlights

  • Revenue was $546.1 million in Q1 2025 compared to $479.4 million in Q1 2024, an increase of $66.7 million or 13.9%.

  • Adjusted EBITDA1 was $75.8 million in Q1 2025 compared to $67.1 million in Q1 2024, an increase of 12.9%.

  • Net income was $15.4 million in Q1 2025 compared to net income of $9.0 million in Q1 2024, an increase of $6.4 million.

  • Declared a quarterly dividend of $0.18 per share to be paid on July 15, 2025.

“We are pleased with our strong first-quarter results, especially considering the uncertain and volatile economic environment,” stated KP Tissue’s Chief Executive Officer, Dino Bianco. “Adjusted EBITDA reached $75.8 million in the quarter on revenue that increased nearly 14% year-over-year. Revenue for the Consumer segment was driven by higher sales volume in Canada and in the U.S., and improved pricing. Our Away-from-Home business, which has been rebranded Kruger PRO, also generated higher sales volume than the same period last year, although profitability was unfavourably impacted by freight costs, warehousing costs and the purchase of external products. We expect that our newly deployed LDC paper machine in Sherbrooke will essentially meet all in-house paper requirements beginning in the second quarter of 2025. The LDC paper machine and new facial tissue converting line, part of the overall Sherbrooke Expansion Project, have exceeded start-up expectations, while TAD paper machine and converting output remains strong year-over-year.”

“Given the changing tariff announcements affecting North America, the impact to our business in the first quarter was not significant. We continue to closely monitor the impact of potential tariffs on our business and have developed contingency plans to mitigate any financial risk,” Mr. Bianco added.

Outlook for Q2 2025
Assuming a similar tariff environment, we expect Q2 2025 Adjusted EBITDA1 to be in the range of $70 million to $75 million.